Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-22

Clinical Trial Update: Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive Esophagitis [Phase 3]

View source ↗

Summary

Phase 3 trial update on the efficacy and safety of Dexlansoprazole for healing and maintaining healing of erosive esophagitis. The study was terminated but resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXLANSOPRAZOLE (DEXLANSOPRAZOLE)

Snippet

Sponsor: Takeda | Conditions: Erosive Esophagitis | Phase 3 | Status: TERMINATED | Results posted: 2019-02-22